Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
62,912,484
-
Total 13F shares
-
56,087,049
-
Share change
-
+490,688
-
Total reported value
-
$182,279,127
-
Put/Call ratio
-
695%
-
Price per share
-
$3.25
-
Number of holders
-
125
-
Value change
-
+$1,568,950
-
Number of buys
-
56
-
Number of sells
-
54
Institutional Holders of MACROGENICS INC - Common Stock (MGNX) as of Q4 2024
As of 31 Dec 2024,
MACROGENICS INC - Common Stock (MGNX) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,087,049 shares.
The largest 10 holders included
Bellevue Group AG, ARMISTICE CAPITAL, LLC, BlackRock, Inc., VANGUARD GROUP INC, WASATCH ADVISORS LP, Frazier Life Sciences Management, L.P., MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
125
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.